Explore the Global Urinary Retention Therapeutics Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Urinary Retention Therapeutics Market

Key Insight

Demand for urinary retention therapeutics will increase through 2036, with anticholinergic and antispasmodic agents at 42.9% of the drug class in 2026. The market was valued at USD 4.02 billion in 2025 and is expected to be worth USD 9.00 billion by 2036, creating an incremental opportunity of USD 4.67 billion.

May 23, 2026

Anurag Sharma

286 Pages

Cite this Report

Urinary Retention Therapeutics Market

https://www.futuremarketinsights.com/reports/urinary-retention-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Ajanta Pharma Ltd
Apotex Inc
Aurobindo Pharma
Breckenridge Pharmaceutical
Lupin
Marksans Pharma
Sun Pharmaceutical Industries Ltd
Berkshire Hathaway
Torrent Pharmaceuticals Ltd
ZydusCadila

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Urinary Retention Therapeutics Market

Key Players

Similar Industry Reports